Home > Boards > Canadian > Biotechs >

Trillium Therapeutics Inc. (TRIL)

TRIL RSS Feed
Add TRIL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/13/2019 11:10:38 AM - Followers: 45 - Board type: Free - Posts Today: 0

Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR)

Home: http://trilliumtherapeutics.com/trillium-home/default.aspx

 

Trillium Therapeutics Inc. 
2488 Dunwin Drive 
Mississauga, Ontario, 
Canada L5L 1J9 
Tel: +1 416.595.0627

 

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (“do not eat”) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (“eat”) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties. Stemming from this platform, the company’s most advanced preclinical program is an orally-available bromodomain inhibitor, followed by an epidermal growth factor receptor antagonist with increased uptake in the brain. In addition, a number of compounds directed at undisclosed immuno-oncology targets are currently in the discovery phase. 

 

SEC filings:  http://www.nasdaq.com/symbol/tril/sec-filings

 

Twitter:  https://twitter.com/search?q=%24TRIL&src=ctag

 

Quote:  https://www.google.com/finance?q=NASDAQ%3ATRIL&ei=dWJkV-kHiKV5wPiX4As

 

Canadian Insider:  https://www.canadianinsider.com/company?menu_tickersearch=tr

 
Currency Converter: http://www.bankofcanada.ca/en/rates/converter.html


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Last update 6/17/2016

 

TRIL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRIL News: Report of Foreign Issuer (6-k) 05/13/2019 07:02:04 AM
TRIL News: Trillium Therapeutics Reports First Quarter 2019 Financial Results 05/13/2019 07:00:00 AM
TRIL News: Report of Foreign Issuer (6-k) 04/30/2019 07:03:36 AM
TRIL News: Trillium Announces Management and Board Changes and Provides Corporate Update 04/30/2019 07:00:00 AM
TRIL News: Report of Foreign Issuer (6-k) 04/15/2019 07:01:38 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#594   News: $TRIL Trillium Therapeutics Reports First Quarter 2019 whytestocks 05/13/19 11:10:38 AM
#593   Based on this price action I think you Wildbilly 04/17/19 09:56:23 AM
#592   In this paper it was shown that TTI-621 jondoeuk 04/15/19 01:25:44 PM
#591   I'm looking at a very specific short to Wildbilly 04/12/19 01:50:16 PM
#590   Looks like a reverse split is coming. Will vinmantoo 04/11/19 02:40:31 PM
#589   Here we go, Notice of Non Compliance, following Wildbilly 04/11/19 10:16:55 AM
#588   agreed...acc here Blutribe 04/09/19 10:07:42 PM
#587   Tril going to fill this gap up at $1.00? Sponsoring Thought 04/09/19 04:30:46 PM
#586   Here is a link to the AACR poster https://s22.q4cdn.com/183592819/files/AACR-201 jondoeuk 04/02/19 04:58:40 PM
#585   tmeier I believe you are sooo right seriousonly 04/01/19 06:30:31 PM
#584   Getting ready to rip!! tmeier 04/01/19 08:32:33 AM
#583   Out +.04, I have enough 'consolidating' stocks atm Wildbilly 03/27/19 09:45:04 AM
#582   In TRIL @ .69 on vol., in the Wildbilly 03/25/19 12:20:03 PM
#581   TRIL .69, OVERSOLD last IPO 2/22 .80 ..I Blutribe 03/11/19 10:27:38 AM
#580   AACR: Preclinical characterization of a novel non-cyclic dinucleotide jondoeuk 02/27/19 05:17:26 PM
#579   Yeah and what's it say about such a Wildbilly 02/22/19 01:07:54 PM
#578   Brilliant management move to wait until a 52 vinmantoo 02/22/19 12:49:46 PM
#577   Open -44% Wildbilly 02/22/19 09:54:35 AM
#576   TRIL halted, wicked $15 offering @ $.80/share, warrants Wildbilly 02/22/19 09:08:18 AM
#575   They haven't been active on this or any jondoeuk 12/26/18 02:59:34 PM
#574   When is the company due to run low RUL6T2 12/07/18 03:40:21 PM
#573   NY1972, you still here in $TRIL?? LongRun8 11/09/18 10:22:03 PM
#572   ASH abstract https://ash.confex.com/ash/2018/webprogram/Paper116915.html jondoeuk 11/03/18 06:29:03 PM
#571   Updated data from the intratumoral trial in those jondoeuk 09/08/18 11:40:24 AM
#570   TRIL is in a world of hurt... biotech_researcher 07/24/18 03:10:49 PM
#569   Out @ $5.70 for small gain. Took advantage chmcnfunds 07/18/18 02:22:57 PM
#568   In @ $%.50. Could have done better if chmcnfunds 07/16/18 11:58:17 AM
#567   Bollinger band Volatility Squeeze in the making watch stockboy 03/09/18 08:10:43 AM
#566   TRIL. Liked the targeted science over the last biotech_researcher 12/13/17 01:37:20 PM
#565   Got out a few days ago...didn't and still catty 12/01/17 02:03:35 PM
#564   Re Other non-cancer indications for anti-CD47 NASH: It's Fibrosis, LongRun8 11/24/17 08:58:54 PM
#563   smmallbio: thx. Hope you're enjoying your Thanksgiving catty 11/23/17 04:33:48 PM
#562   It is still at little over $100M market cap. smallbio 11/23/17 12:09:43 AM
#561   Big question now is when to sell?????????? catty 11/22/17 11:20:39 AM
#560   have been following TRIL and just got in catty 11/01/17 01:31:02 PM
#559   Ladeburg on TRIL on ASH smallbio 10/27/17 08:25:08 PM
#558   If you are long TRIL, you want to NY1972 10/19/17 04:58:20 PM
#557   More interesting data: NY1972 10/19/17 04:14:07 PM
#556   I'm still shocked tril hasn't partnered yet. I ronpopeil 10/18/17 02:05:41 PM
#555   Here is the complete result: NY1972 10/18/17 01:50:42 PM
#554   Is there any additional data you can share? Thanks jondoeuk 10/18/17 10:34:11 AM
#553   I copied & pasted from EORTC poster. Your NY1972 10/18/17 09:53:42 AM
#552   I came across something slightly different (see post# 549). jondoeuk 10/18/17 05:43:01 AM
#551   You have to believe big pharma is watching. ronpopeil 10/17/17 10:11:48 PM
#550   From 1 abstract: NY1972 10/17/17 10:02:07 PM
#549   I came across the following (the link appears jondoeuk 10/17/17 09:32:57 AM
#548   The anti-tumor effect of radiation therapy is enhanced jondoeuk 09/23/17 08:06:56 AM
#547   Growth Equity Opportunities V, LLC has filed a wiltonio 06/09/17 04:41:27 PM
#546   TRILLIUM EXPANDS CLINICAL TRIAL WITH TTI-621 TO INCLUDE jondoeuk 06/07/17 01:22:15 PM
#545   Nothing new from Trillium but here is the jondoeuk 06/06/17 07:15:45 PM
PostSubject